Principal Research Scientist I, In Vivo Antibody Discovery

About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.

The Biotherapeutics and Genetics Medicine department within Discovery Research is seeking a highly motivated Principal Scientist to join the in vivo antibody discovery team at AbbVie Bioresearch Center (ABC). The ABC site in Worcester, MA, offers a unique setting where Biotherapeutics discovery, development and manufacturing coexist in one location. The team partners with multidisciplinary groups across AbbVie focused on developing therapies for Immunology, Neuroscience, and Oncology. We utilize innovative approaches for antibody discovery including custom immunization strategies, advanced multiplex screening assays, and best-in-class automation platforms to enable successful antibody discovery against challenging targets. As a member of the in vivo antibody discovery group, you will be responsible for leading innovative immunization-based antibody discovery. You will provide technical and strategic leadership across multiple immune discovery platforms, driving the identification of high-quality therapeutic antibody candidates for challenging targets and advanced antibody modalities. The successful candidate will combine deep expertise in antibody discovery technologies with strong program leadership, cross-functional collaboration, and external partner management.

Lead antibody discovery programs from hit identification, screening, lead selection, and candidate nomination. Design and execute novel antigen engineering strategies and immunization approaches, to maximize immune response quality and diversity. Provide technical leadership across multiple antibody discovery platforms, including B cell-based discovery, immune repertoire screens and hybridoma Lead identification of antibody and VHH modalities for diverse therapeutic programs and multispecifics. Evaluate and implement emerging antibody discovery technologies, including AI-enabled workflows, machine learning, computational biology, and laboratory automation, to expand platform capabilities and accelerate discovery. Direct hybrid discovery campaigns that integrate internal capabilities with external partners while proactively identifying and mitigating scientific/ operational risks. Mentor scientists and provide technical guidance across antibody discovery programs. Contribute to the scientific reputation of the organization through publications, patents, presentations, and external collaborations.

BS, MS, or PhD in immunology, biochemistry, molecular biology, bioinformatics or a related scientific field with typically 6+ (PhD), 12+ (MS), or 14+ (BS) years of industry experience. Deep hands-on expertise in antibody discovery platforms, such as single B cell cloning, immune repertoire screening and hybridoma. Extensive experience designing antigens and novel immunization strategies for challenging therapeutic targets. Strong expertise in hit identification, screening cascade design, lead triage, and lead selection. Experience with VHH discovery platforms using camelids and transgenics. Working knowledge of antibody engineering principles, developability assessment, and sequence liability evaluation. Adept at identifying and working with novel solutions—such as AI-based antigen design, and laboratory automation. Demonstrated ability to critically evaluate and implement new antibody discovery technologies and